cdn mobile

DOH-7 assures availability of HPV vaccine in Central Visayas

By: Niña Mae C. Oliverio - Multimedia Reporter - CDN Digital | November 27,2023 - 08:10 PM

Jera Armendarez

Dr. Jera Armendarez, head of the Non-Communicable Diseases Section of the Department of Health in Central Visayas (DOH-7) said on Monday, Nov. 27, that a vaccine against human papillomavirus (HPV) is available in the region. | CDN File Photo/Niña Mae Oliverio

CEBU CITY, Philippines — The Department of Health in Central Visayas (DOH-7) assured that the vaccine against the human papillomavirus (HPV) is available.

Dr. Jera Armendarez, head of the Non-Communicable Disease Section at DOH-7, gave the assurance during a forum about HPV on Monday, November 27,  inside a mall in Cebu City.

HPV is a sexually transmitted disease that may cause cancers and diseases like cervical cancer, vaginal and vulvar cancers, penile cancer, anal cancer, oropharyngeal cancer, and genital warts.

“We will be emphasizing sa karon nga naa gyud tay readily available na HPV [vaccine] sa ages 9 to 15 nga bata para duha lang ka doses ang atong mahatag,” Armendarez said.

She added that the vaccine can also be accessed for free at rural health units (RHUs), but if patients choose to avail themselves of it in private hospitals, they would need to pay more or less than P3,000.

READ: HPV : Why men, women should be vaccinated against the virus that can lead to cancer

During the 24th Philippine National Immunization Conference in Cebu City last November 11, Dr. Jonathan Lim, a pediatric infectious diseases specialist, advised individuals as young as nine years old to consider getting vaccinated as a preventive measure against this infection.

By choosing vaccination at an early age, Lim stated that individuals could reduce the risk of contracting the infection and its associated consequences.

For individuals aged nine to 14 years old, a two-dose regimen is recommended, with the first dose administered, followed by the second dose one month later. On Monday, Armendarez emphasized to reporters the importance of preventive measures against HPV, noting that cervical cancer stands as the second most common cancer affecting women in the Philippines.

She highlighted that cervical cancer “is very preventable,” especially when implementing preventive measures such as vaccination.

Cancer assistance fund

Among the programs offered by DOH are the Cancer Assistance Fund (CAF) and the Cancer and Supportive-Palliative Medicine Access Program (CSP-Map).

Armendarez mentioned that the DOH would screen patients for HPV, and if they tested positive, they would provide the Cancer Assistance Fund (CAF), granting P150,000 annually per patient. The CAF covers diagnostics, treatment, and medicines, and cancer patients can also access medicines through the Cancer and Supportive-Palliative Medicine Access Program (CSP-Map).

Between January and June 2023, 17 cervical cancer patients received their CAF at the Vicente Sotto Memorial Medical Center (VSMMC) in Cebu City. Unfortunately, no data is available from July to November since the current information from VSMMC only covers January to June.

Armendarez clarified that she couldn’t provide details from other hospitals in the region as VSMMC is the sole access site for DOH-7. / with reports from Rashe Zoe Sophia Piquero

ALSO READ:

DOH-7 needs takers for HPV vaccines

PHO gives HPV vaccines to Capitol employees

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Department of Health in Central Visayas (DOH-7), human pappilomavirus or HPV, vaccines
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.